Suchergebnisse - (Person:"Gökmen-Polar, Yesim")

PubPharm (109)

1

Triple Negative Breast Cancers : An Obsolete Entity?

enthalten in: Clinical breast cancer | 2024

von Keskinkılıc, M. | Gökmen-Polar, Y. | Badve, S.

2

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

enthalten in: JCO precision oncology | 2023

von Stecklein, S. | Barlow, W. | Pusztai, L. | +14

3

The Role of ESRP1 in the Regulation of PHGDH in Estrogen Receptor-Positive Breast Cancer

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2023

von Gökmen-Polar, Y. | Gu, Y. | Polar, A. | +2

4

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model

enthalten in: Cancers | 2023

von Ghose, S. | Cho, S. | Ginty, F. | +9

5

A predictor of response in HER2+ breast cancer-at last!

enthalten in: Journal of the National Cancer Institute | 2023

von Badve, S. | Gökmen-Polar, Y.

CommentOn: J Natl Cancer Inst. 2023 Mar 9;115(3):332-336. - PMID 36576009

6

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) using Generative Adversarial Network Augmented Deep Learning Model

enthalten in: bioRxiv.org | 2023

von Ghose, S. | Cho, S. | Ginty, F. | +9

7

Targeting the Tumor-Tumor Microenvironment Crosstalk

enthalten in: Expert opinion on therapeutic targets | 2023

von Badve, S. | Gökmen-Polar, Y.

8

Spatially variant immune infiltration scoring in human cancer tissues

enthalten in: NPJ precision oncology | 2022

von Allam, M. | Hu, T. | Lee, J. | +7

9

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

enthalten in: Cancers | 2022

von Badve, S. | Cho, S. | Lu, X. | +10

10

Is conservative management of ductal carcinoma in situ risky?

enthalten in: NPJ breast cancer | 2022

von Zheng, L. | Gökmen-Polar, Y. | Badve, S.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]